TECH
Bio-Techne Corp
NASDAQ: TECH · HEALTHCARE · BIOTECHNOLOGY
$72.03
-0.06% today
Updated 2026-07-29
Market cap
$11.24B
P/E ratio
103.03
P/S ratio
9.28x
EPS (TTM)
$0.70
Dividend yield
0.45%
52W range
$43 – $72
Volume
5.2M
Bio-Techne Corp (TECH) Financial Forecast & Price Target 2030
Revenue-driven projection model with historical context.
Price target summary
Current price
$72.03
12-Month target
$11.32
2030 Target
—
Intrinsic (DCF)
$199.78
Financial forecast
| Metric | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Revenue | $0.9B | $1.1B | $1.1B | $1.2B | $1.2B |
| EPS | — | — | — | — | — |
CAGR applied: — (capped 20%) · P/E: 25.00x (capped 25x) · Margin: 9.05%
Methodology
CAGR-based projection model. Research-backed estimates are being generated — check back soon for analyst consensus and management guidance.